N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid

C47H65F3N10O10 — CID 44554697

IUPACN-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid
SMILESCCC[C@H](NC(=O)[C@@H]1CNC[C@@H]1NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(=O)C(=O)NCC(=O)N[C@H](C(=O)N(C)C)c1ccccc1.O=C(O)C(F)(F)F
InChIInChI=1S/C45H64N10O8.C2HF3O2/c1-4-14-32(39(57)44(62)49-27-36(56)53-38(45(63)55(2)3)30-19-12-7-13-20-30)50-40(58)31-24-47-25-34(31)52-41(59)33(23-28-15-8-5-9-16-28)51-43(61)37(29-17-10-6-11-18-29)54-42(60)35-26-46-21-22-48-35;3-2(4,5)1(6)7/h7,12-13,19-22,26,28-29,31-34,37-38,47H,4-6,8-11,14-18,23-25,27H2,1-3H3,(H,49,62)(H,50,58)(H,51,61)(H,52,59)(H,53,56)(H,54,60);(H,6,7)/t31-,32+,33+,34+,37+,38+;/m1./s1
InChIKeyDDPQWPHBSNLUKM-XVAGVMBZSA-N
MW987.09 g/mol
LogP1.86
Rot. Bonds20

About N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid

N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid (PubChem CID 44554697) has the molecular formula C47H65F3N10O10 and a molecular weight of 987.09 g/mol. Its IUPAC name is N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid.

Molecular Properties

Compound NameN-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid
PubChem CID44554697
Molecular FormulaC47H65F3N10O10
Molecular Weight987.09 g/mol
Exact Mass986.48
IUPAC NameN-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid
SMILESCCC[C@H](NC(=O)[C@@H]1CNC[C@@H]1NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(=O)C(=O)NCC(=O)N[C@H](C(=O)N(C)C)c1ccccc1.O=C(O)C(F)(F)F
InChIInChI=1S/C45H64N10O8.C2HF3O2/c1-4-14-32(39(57)44(62)49-27-36(56)53-38(45(63)55(2)3)30-19-12-7-13-20-30)50-40(58)31-24-47-25-34(31)52-41(59)33(23-28-15-8-5-9-16-28)51-43(61)37(29-17-10-6-11-18-29)54-42(60)35-26-46-21-22-48-35;3-2(4,5)1(6)7/h7,12-13,19-22,26,28-29,31-34,37-38,47H,4-6,8-11,14-18,23-25,27H2,1-3H3,(H,49,62)(H,50,58)(H,51,61)(H,52,59)(H,53,56)(H,54,60);(H,6,7)/t31-,32+,33+,34+,37+,38+;/m1./s1
InChIKeyDDPQWPHBSNLUKM-XVAGVMBZSA-N
XLogP1.86
TPSA287.09 Ų
H-Bond Donors8
H-Bond Acceptors12
Rotatable Bonds20
Heavy Atoms70
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500987.09
LogP ≤ 51.86
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid?
The IUPAC name of N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid (CID 44554697) is N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid.
What is the SMILES notation for N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid?
The canonical SMILES for N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid is CCC[C@H](NC(=O)[C@@H]1CNC[C@@H]1NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(=O)C(=O)NCC(=O)N[C@H](C(=O)N(C)C)c1ccccc1.O=C(O)C(F)(F)F.
What is the InChIKey of N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid?
The InChIKey is DDPQWPHBSNLUKM-XVAGVMBZSA-N. The full InChI is InChI=1S/C45H64N10O8.C2HF3O2/c1-4-14-32(39(57)44(62)49-27-36(56)53-38(45(63)55(2)3)30-19-12-7-13-20-30)50-40(58)31-24-47-25-34(31)52-41(59)33(23-28-15-8-5-9-16-28)51-43(61)37(29-17-10-6-11-18-29)54-42(60)35-26-46-21-22-48-35;3-2(4,5)1(6)7/h7,12-13,19-22,26,28-29,31-34,37-38,47H,4-6,8-11,14-18,23-25,27H2,1-3H3,(H,49,62)(H,50,58)(H,51,61)(H,52,59)(H,53,56)(H,54,60);(H,6,7)/t31-,32+,33+,34+,37+,38+;/m1./s1.
What are the key properties of N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid?
N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid has a molecular weight of 987.09 g/mol, XLogP of 1.86, 20 rotatable bonds, 8 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S)-1-cyclohexyl-2-[[(2S)-3-cyclohexyl-1-[[(3R,4R)-4-[[(3S)-1-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxohexan-3-yl]carbamoyl]pyrrolidin-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrazine-2-carboxamide;2,2,2-trifluoroacetic acid is sourced from PubChem (CID 44554697), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).